<?xml version="1.0"  encoding="UTF-8"?>
<prs:study_collection xmlns:prs="http://clinicaltrials.gov/prs">
<clinical_study>
    <id_info>
        <provider_name>NLM_DES</provider_name>
        <provider_study_id>S0006HWA</provider_study_id>
        <org_name>AddenbrookesH</org_name>
        <org_study_id>1234</org_study_id>
    </id_info>
    <is_fda_regulated>No</is_fda_regulated>
    <is_section_801>None</is_section_801>
    <delayed_posting>None</delayed_posting>
    <is_ind_study>No</is_ind_study>
    <brief_title>Test Study for my tool</brief_title>
    <acronym>TEST</acronym>
    <official_title>Test Study for my tool</official_title>
    <sponsors>
        <lead_sponsor>
            <agency>Cambridge University Hospitals NHS Foundation Trust</agency>
        </lead_sponsor>
        <resp_party>
            <resp_party_type>Principal Investigator</resp_party_type>
            <investigator_username>djayne</investigator_username>
            <investigator_title>Dr</investigator_title>
            <investigator_affiliation>Cambridge University Hospitals NHS Foundation Trust</investigator_affiliation>
            <name_title/>
            <organization/>
            <phone/>
            <phone_ext/>
            <email/>
        </resp_party>
    </sponsors>
    <oversight_info>
        <irb_info>
            <approval_status>Exempt</approval_status>
        </irb_info>
        <has_dmc>No</has_dmc>
        <fda_regulated_drug>No</fda_regulated_drug>
        <fda_regulated_device>No</fda_regulated_device>
        <post_prior_to_approval>None</post_prior_to_approval>
    </oversight_info>
    <brief_summary>
        <textblock>Test Trial </textblock>
    </brief_summary>
    <detailed_description>
        <textblock></textblock>
    </detailed_description>
    <overall_status>Completed</overall_status>
    <why_stopped/>
    <verification_date>2021-07</verification_date>
    <start_date>2020-01-01</start_date>
    <start_date_type>Actual</start_date_type>
    <end_date/>
    <last_follow_up_date>2021-02-01</last_follow_up_date>
    <last_follow_up_date_type>Actual</last_follow_up_date_type>
    <primary_compl_date>2021-01-01</primary_compl_date>
    <primary_compl_date_type>Actual</primary_compl_date_type>
    <study_design>
        <study_type>Interventional</study_type>
        <interventional_design>
            <interventional_subtype>Treatment</interventional_subtype>
            <phase>Phase 2</phase>
            <assignment>Parallel Assignment</assignment>
            <model_description>
                <textblock></textblock>
            </model_description>
            <allocation>Randomized</allocation>
            <masking/>
            <no_masking>true</no_masking>
            <masked_subject>false</masked_subject>
            <masked_caregiver>false</masked_caregiver>
            <masked_investigator>false</masked_investigator>
            <masked_assessor>false</masked_assessor>
            <masking_description>
                <textblock></textblock>
            </masking_description>
            <control/>
            <number_of_arms>2</number_of_arms>
        </interventional_design>
    </study_design>
    
    <enrollment>400</enrollment>
    <enrollment_type>Actual</enrollment_type>
    <condition>Vasculitis</condition>
    <arm_group>
        <arm_group_label>Control</arm_group_label>
        <arm_type>No Intervention</arm_type>
        <arm_group_description>
            <textblock></textblock>
        </arm_group_description>
    </arm_group>
    <arm_group>
        <arm_group_label>Ritazarem</arm_group_label>
        <arm_type>Experimental</arm_type>
        <arm_group_description>
            <textblock></textblock>
        </arm_group_description>
    </arm_group>
    <intervention>
        <intervention_type>Drug</intervention_type>
        <intervention_name>ritazarem</intervention_name>
        <intervention_description>
            <textblock>A drug that we want to look at</textblock>
        </intervention_description>
        <arm_group_label>Ritazarem</arm_group_label>
    </intervention>
    <eligibility>
        <study_population>
            <textblock></textblock>
        </study_population>
        <sampling_method/>
        <criteria>
            <textblock>Inclusion Criteria:&#xd;
  - Vasculitis&#xd;
&#xd;
Exclusion Criteria:&#xd;
  - </textblock>
        </criteria>
        <healthy_volunteers>No</healthy_volunteers>
        <gender>All</gender>
        <gender_based>No</gender_based>
        <gender_description>
            <textblock></textblock>
        </gender_description>
        <minimum_age>18 Years</minimum_age>
        <maximum_age> N/A</maximum_age>
    </eligibility>
    <overall_contact>
        <first_name>Simon</first_name>
        <middle_name/>
        <last_name>Bond</last_name>
        <degrees/>
        <phone>+441223596475</phone>
        <phone_ext/>
        <email>simon.bond@addenbrookes.nhs.uk</email>
    </overall_contact>
    <overall_contact_backup>
        <first_name/>
        <middle_name/>
        <last_name/>
        <degrees/>
        <phone/>
        <phone_ext/>
        <email/>
    </overall_contact_backup>
    <location>
        <facility>
            <name>Cambridge Clinical Trials Unit</name>
            <address>
                <city>Cambridge</city>
                <state/>
                <country>United Kingdom</country>
                <zip>cb20qq</zip>
            </address>
        </facility>
        <status>Completed</status>
        <contact>
            <first_name>Simon</first_name>
            <middle_name/>
            <last_name>Bond</last_name>
            <degrees/>
            <phone>01223596475</phone>
            <phone_ext/>
            <email>simon.bond@addenbrookes.nhs.uk</email>
        </contact>
        <contact_backup>
            <first_name/>
            <middle_name/>
            <last_name/>
            <degrees/>
            <phone/>
            <phone_ext/>
            <email/>
        </contact_backup>
    </location>
    <ipd_sharing_statement>
        <sharing_ipd>No</sharing_ipd>
        <ipd_description>
            <textblock></textblock>
        </ipd_description>
        <ipd_info_type_protocol>false</ipd_info_type_protocol>
        <ipd_info_type_sap>false</ipd_info_type_sap>
        <ipd_info_type_icf>false</ipd_info_type_icf>
        <ipd_info_type_csr>false</ipd_info_type_csr>
        <ipd_info_type_analytic_code>false</ipd_info_type_analytic_code>
        <ipd_time_frame>
            <textblock></textblock>
        </ipd_time_frame>
        <ipd_access_criteria>
            <textblock></textblock>
        </ipd_access_criteria>
        <ipd_url>http://</ipd_url>
    </ipd_sharing_statement>
<rrs:result xmlns:rrs="http://clinicaltrials.gov/rrs">
   <certainAgreement/>
   <outcomeMeasures>
      <outcomeMeasure>
         <measureRows/>
         <measureDescription/>
         
         <timeFrame/>
         <title>Time to relapse</title>
         <anticipatedResultPostingDate/>
         <measureType>Primary</measureType>
         <outcomeMeasureAnalyses/>
         <outcomeReportingGroups/>
      </outcomeMeasure>
   </outcomeMeasures>
   <pointOfContact/>
   <reportedEvents>
      <frequentAdverseEvents/>
      <interventionGroups>
         <interventionGroup id="ReportedEvents-InterventionGroup.1">
            <description>control arm</description>
            
            <title>Control</title>
         </interventionGroup>
         <interventionGroup id="ReportedEvents-InterventionGroup.2">
            <description>ritazarem: A drug that we want to look at</description>
            
            <title>Ritazarem</title>
         </interventionGroup>
      </interventionGroups>
      <seriousAdverseEvents/>
   </reportedEvents>
</rrs:result></clinical_study>
</prs:study_collection>
